Acne vulgaris Epidemiology Summary
- Acne vulgaris is a common chronic inflammatory disorder of the pilosebaceous unit characterized by the development of comedones, papules, pustules, nodules, and, in severe cases, cysts and permanent scarring.
- The disease encompasses multiple clinical forms, including comedonal, inflammatory, nodulocystic, truncal, adolescent, and adult acne, each associated with distinct clinical characteristics and severity patterns.
- Acne vulgaris is one of the most prevalent dermatological disorders worldwide, affecting approximately 85% of adolescents and young adults, although it may persist into or first present during adulthood. Disease prevalence and severity vary across age groups, sex, and geographic regions.
- According to a secondary analysis of a epidemiological studies, acne vulgaris affects individuals across all age groups in the US, with 65.2% of treated cases occurring in females, 36.5% in adolescents aged 12–17 years, and 61.9% in adults aged =18 years. The authors noted that these estimates likely underestimate the true population burden because the analysis included only treated cases.
- The pathophysiology of acne vulgaris is multifactorial and involves increased sebum production, follicular hyperkeratinization, proliferation of Cutibacterium acnes, and activation of inflammatory pathways, with genetic, hormonal, and environmental factors contributing to disease susceptibility and severity.
- Hormonal influences, particularly androgen-mediated stimulation of sebaceous gland activity, genetic predisposition, inflammatory responses, and alterations in the skin microbiome are considered key contributors to disease development and progression.
- Beyond visible skin lesions, acne vulgaris is frequently associated with post-inflammatory hyperpigmentation, permanent scarring, and psychosocial consequences such as reduced self-esteem, anxiety, depression, and impaired quality of life, contributing substantially to overall disease burden.
- Growing understanding of the genetic, hormonal, inflammatory, and microbiome-related basis of acne vulgaris continues to refine epidemiological characterization, improve disease classification, and enhance identification of distinct patient subgroups across the acne spectrum.
DelveInsight’s “Acne Vulgaris Epidemiology Forecast – 2036" report delivers an in-depth understanding of Acne Vulgaris historical and forecasted epidemiology trends in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.
The Acne Vulgaris epidemiology report provides a comprehensive analysis of prevalent cases, capturing the number of patients across the 7MM. It includes detailed segmentation by severity, gender, and age along with regional distribution. The report evaluates historical and forecasted prevalence trends (2026–2036), highlighting variations in disease occurrence and diagnosis patterns, and offering insights into the evolving burden of newly diagnosed Acne Vulgaris cases.
|
Study Period |
2022–2036 |
|
Historical Year |
2022–2025 |
|
Forecast Period |
2026–2036 |
|
Base Year |
2025 |
|
Geographies Covered |
ü North America : The US ü Europe: Germany, France, Italy, Spain and the UK ü Asia-Pacific: Japan |
|
Acne Vulgaris Epidemiology Segmentation Analysis |
Patient Burden Assessment · Total Prevalent Cases of Acne Vulgaris · Total Diagnosed Prevalent Cases of Acne Vulgaris · Severity-specific Diagnosed Prevalent Cases of Acne Vulgaris · Age-specific Diagnosed Prevalent Cases of Acne Vulgaris · Gender-specific Diagnosed Prevalent Cases of Acne Vulgaris |
|
Analysis |
· Addressable Patient Population · KOL views |
Acne Vulgaris Understanding
Acne Vulgaris Overview and Diagnosis
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit characterized by the development of comedones, papules, pustules, nodules, and, in severe cases, cysts and permanent scarring. The disease results from a complex interplay among increased sebum production, follicular hyperkeratinization, proliferation of Cutibacterium acnes, and inflammatory responses, with genetic, hormonal, environmental, and lifestyle factors contributing to disease susceptibility and severity. Acne vulgaris encompasses several clinical forms, ranging from predominantly comedonal and inflammatory acne to nodulocystic disease, resulting in considerable heterogeneity in clinical presentation, disease severity, and long-term outcomes.
The diagnosis of acne vulgaris is primarily based on clinical evaluation, including lesion morphology, anatomical distribution, and disease severity assessment. Diagnostic evaluation may incorporate validated grading systems to classify disease severity and monitor treatment response, while laboratory investigations are generally reserved for patients with suspected underlying endocrine disorders or atypical clinical presentations. Advances in understanding the molecular, hormonal, and microbiome-related mechanisms underlying acne have improved disease characterization and patient stratification. Given the potential for permanent scarring and substantial psychosocial burden, early diagnosis and accurate severity assessment remain essential for optimizing long-term outcomes and reducing disease burden.
Further details related to country-based variations are provided in the report...
Acne Vulgaris Epidemiology
The Acne Vulgaris epidemiology section offers a comprehensive overview of both the historical and current patient population, along with forecasted epidemiological trends across the seven major markets (7MM). It analyzes the factors influencing these trends through published research, expert insights, and key opinion leader (KOL) perspectives. Additionally, this section presents estimates of the diagnosed patient population, highlights evolving disease patterns, and outlines the key assumptions used in developing the epidemiological forecasts.
Key Findings from Acne Vulgaris Epidemiological Analysis and Forecast
- According to secondary research, the diagnosed prevalence of acne among adolescents and young people in the UK reached 14.6% by 2021, representing a 7.4% increase compared with 1990. When self-managed cases are also considered, acne is estimated to affect up to 95% of adolescents, highlighting the substantial underrecognition of the true disease burden.
- Based on literary search, a Japan-based epidemiological study, 58.6% of students were affected by acne vulgaris, with a mean age of onset of 13.3 years, indicating that the disease commonly develops during early adolescence.
- Major factors contributing to regional differences in the prevalence and burden of acne vulgaris across the 7MM include variations in genetic predisposition, hormonal and environmental influences, diagnostic practices, and disease awareness. The epidemiology of acne vulgaris is expected to evolve during the forecast period (2026–2036), driven by increasing awareness, earlier diagnosis, improved disease characterization, and growing recognition of acne across adolescent and adult populations.
Further details are provided in the report...
Industry Experts and Physician Views for Acne Vulgaris
To keep up with Acne Vulgaris epidemiology trends, we take Key Opinion Leaders (KOLs) and Subject Matter Experts (SMEs) opinions working in the domain through primary research to fill the data gaps and validate our secondary research. Industry experts were contacted for insights on the Acne Vulgaris epidemiology, prevalence trends, regional distribution, patient demographics, diagnostic rates, and real-world disease burden patterns in Acne Vulgaris, including MD, PhD, Instructor, Postdoctoral Researcher, Professor, Researcher, and others.
DelveInsight’s analysts connected with 10+ KOLs to gather insights at country level. Centers such as the Memorial Sloan Kettering Cancer Center, University of California San Francisco, State University of New York Upstate Medical University, etc. were contacted.
Their opinion helps understand and validate Acne Vulgaris epidemiological trends, highlight key gaps in diagnosis and disease burden, provide deeper epidemiological context, and support strategic decisions for patient identification and disease monitoring in Acne Vulgaris.
Scope of the Acne Vulgaris Epidemiology Report
- The report covers a segment of key epidemiological highlights, an executive summary, and a descriptive overview of acne vulgaris, including its causes, risk factors, and factors influencing disease occurrence.
- Comprehensive insights are provided into prevalence trends and forecasts, along with the future growth potential of prevalence rates and evolving patterns of disease detection across the 7MM.
- Additionally, the report includes detailed segmentation of prevalent cases by severity, gender and age offering a granular view of the epidemiological landscape.
- A thorough assessment of historical and forecasted prevalence data, along with underlying assumptions and methodology, is included, providing a clear understanding of disease burden across the 7MM.
- The report provides strategic insights by highlighting trends in prevalence, diagnostic gaps, and regional variations, supported by expert opinions and epidemiological analysis to better understand and project the Acne Vulgaris disease burden.
Report Insights
- Acne vulgaris prevalence forecast, epidemiological burden, segmentation, trends, and opportunity assessment.
Acne Vulgaris Epidemiology Report Key Strengths
- Epidemiology-based (EPI - based) bottom-up forecasting
- Artificial Intelligence (AI) - enabled epidemiology research report
- 11-year forecast
- Acne Vulgaris epidemiological outlook (North America, Europe, Asia-Pacific)
- Acne Vulgaris Burden trends (by geography)
Acne Vulgaris Epidemiology Report Assessment
- Acne Vulgaris Diagnostic Trends
- Acne Vulgaris Epidemiological Gaps
- Acne Vulgaris Development Trends
- Acne Vulgaris Emerging Research Focus
- Acne Vulgaris Disease Burden Attractiveness
- Acne Vulgaris Qualitative Epidemiological Insights
FAQs
- What was the acne vulgaris prevalent patient population and distribution (%) in 2025, and how will it evolve by 2036? What factors are driving these trends?
- What are the anticipated variations in prevalence and diagnosis rates across different geographies?
- What will be the future diagnosis and epidemiological trends of acne vulgaris?
- What are the disease risks, burden, and key epidemiological gaps in acne vulgaris? What are the growth opportunities based on the patient population across the 7MM?
- How will changes in prevalence and diagnosis impact the overall epidemiological landscape?
- What are the current diagnosis practices and epidemiology trends of acne vulgaris in the US, Europe, UK, and Japan?
Reasons to Buy Acne Vulgaris Epidemiology Report
- The report will help in developing strategies by understanding the latest trends and changing epidemiology of acne vulgaris.
- Bottom-up forecasting builds from the prevalent patient population, delivering a robust, data-driven epidemiological approach.
- Insights on patient burden/prevalence, evolution in diagnosis, and factors contributing to changes in disease epidemiology during the forecast years.
- Understand the epidemiological opportunities across varying geographies and growth potential over the coming years.
- Identifying key trends in disease prevalence will help anticipate shifts in the epidemiological landscape.
- Detailed analysis and segmentation of prevalent cases to provide visibility around high-burden patient groups.
- To understand KOLs’ perspectives on diagnosis challenges and gaps in disease identification.
- Detailed insights on epidemiological unmet needs to support improved disease tracking and diagnosis strategies.
- This Artificial Intelligence (AI)-enabled report summarizes complex epidemiological datasets into clear, actionable insights for stakeholders, investors, and healthcare providers.
